AMAastha Malla

Aastha Malla

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aastha Malla has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    46,XX pure gonadal dysgenesis presenting with a massive yolk sac tumor: a diagnostic and surgical challenge – a rare case report

    by Aastha Malla, Manvi Mukherjee, Kapil Khanal, Shweta Karna, Nisha Kharel, Neeta Katuwal, Pooja Paudyal, Sagar Mandal

    Introduction and importance: Pure gonadal dysgenesis (PGD) is a rare condition that presents as phenotypic female individuals with nonfunctional gonads. The development of malignant germ cell tumors like yolk sac tumors (YSTs) in PGD is exceedingly rare, with a less than 5% risk in 46XX PGD and a 30–40% risk in 46XY PGD. We present a case of YST in a 27-year female with PGD. Case presentation: A 27-year-old woman with primary amenorrhea presented with acute lower abdominal pain and a 20 cm adnexal mass. Hormonal assays showed hypergonadotropic hypogonadism. Alpha-fetoprotein (AFP) exceeded 2000 ng/mL. Magnetic resonance imaging (MRI) demonstrated a large abdominopelvic mass and infantile uterus. Karyotype confirmed 46,XX. The patient underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy followed by bleomycin, etoposide, and cisplatin (BEP) chemotherapy. Post-treatment AFP levels normalized, and six-month imaging showed no residual disease. Clinical discussion: The genetic basis of PGD is complex, involving numerous genes that result in nonfunctional streak gonads. YSTs are aggressive malignancies typically found in dysgenetic gonads, which are prone to neoplastic transformation, though they are rare presentation. Imaging such as ultrasonography and MRI plays a key role in diagnosing both the extent of gonadal dysgenesis and any associated tumors. Surgical pathway is the cornerstone of treatment with BEP regimen as adjuvant chemotherapy. Conclusion: This rare case highlights the importance of considering YST in PGD patients with abdominal masses and elevated tumor markers and demonstrates that prompt surgical and chemotherapeutic intervention yields favorable outcomes.

  • Open Access

    Postoperative hormonal modulation in a patient with granulosa cell tumor and myasthenia gravis: a gyneco-oncologic perspective

    by Manvi Mukherjee, Sagar Mandal, Abhishek Kumar Shah, Aastha Malla, Bishal Khaniya, Sunita Pun

    Introduction and importance: Perioperative management of granulosa cell tumors (GCTs) becomes significantly more complex in patients with neuromuscular conditions such as myasthenia gravis (MG). Herein, we describe a case of surgically managed stage I GCT in a woman with MG and hypothyroidism. This case is unique because the patient developed postoperative cardiac instability attributed to abrupt estrogen withdrawal after oophorectomy, which resolved rapidly with estrogen replacement. Case presentation: A 38-year-old woman (gravida 0, para 0), married for 8 years, and who is a known case of MG and hypothyroidism presented to our center with a 2-week history of dull lower abdominal pain, intensifying during menstruation. The MRI raised a suspicion of malignancy after which the patient was taken for comprehensive staging surgery in which abdominal hysterectomy and bilateral salpingo-oophorectomy were performed. On post-op day 3, she developed palpitations, chest discomfort, progressive fatigue, and drowsiness. The patient was successfully managed with oral estradiol and discharged on post-op day 9. Clinical discussion: From a gynecologic oncologic perspective, comprehensive surgical staging remains the standard of care for apparent early-stage AGCT. In our case, the patient’s co-morbid MG added significant complexity to the perioperative planning. The cardiac arrhythmia developed as a result of sudden withdrawal of estrogen due to oophorectomy was successfully managed with oral estradiol, and the patient was successfully discharged. Conclusion: Prompt recognition of post-oophorectomy hormonal withdrawal and judicious use of estrogen therapy may be essential in mitigating postoperative complications in hormone-sensitive tumors like AGCTs.

  • Open Access

    Intrapartum posterior cul-de-sac rupture, a clinical enigma: a case report

    by Manvi Mbbs Mukherjee, Sagar Mbbs Mandal, Aastha Mbbs Malla, Pooja Mbbs Paudyal, Suniti Mbbs Rawal, Neeta Mbbs Katuwal

    Introduction and importance: Posterior cul-de-sac rupture is a rare intrapartum complication with non-specific symptoms that impede timely diagnosis. Reported risk factors include genital tract anomalies, prior pelvic infection, cesarean scar, and pharmacologic induction (e.g., misoprostol). Case presentation: A 29-year-old primigravida presented at our Obstetrics and Gynecology department with fetal growth restriction at 38 weeks of gestation. Ultrasound revealed fetal growth restriction (an estimated fetal weight of 2196 g, <10th percentile), a single umbilical artery, and normal Doppler findings. Her cervical os was closed, so labor was induced with mifepristone followed by misoprostol. This was followed by spontaneous rupture of membranes. An emergency cesarean section was performed due to fetal distress, revealing a 5-cm tear extending from the pouch of Douglas to the cervicovaginal junction, repaired in layers. Postoperative antibiotics were administered, and she recovered well, with follow-up scheduled after 6 weeks. Clinical discussion: Intrapartum rupture of the posterior cul-de-sac during induced labor is rare. Various circumstances have been associated with posterior vaginal wall ruptures, including vaginal atresia and previous pelvic infections. Despite the absence of identifiable risk factors, induction with misoprostol may have contributed to the rupture. A hallmark symptom is severe abdominal pain, which warrants attention even without known risk factors. Therefore, vigilance is crucial for diagnosing concealed vaginal wall ruptures during labor, particularly in the context of unexplained severe pain. Conclusion: It is crucial to suspect the possibility of a hidden vaginal wall rupture during labor, particularly when there is unexplained acute pain. Future studies should compare outcomes across parity groups and evaluate induction-related risk.